Congress Proposes Amendment Allowing VA Doctors to Recommend Medical Cannabis to Veterans

A bipartisan group of lawmakers in the U.S. House of Representatives has introduced an amendment that would grant military veterans access to medical cannabis recommendations through Department of Veterans Affairs (VA) physicians. The proposal, filed by Reps. Brian Mast (R-FL), Dave Joyce (R-OH), and Dina Titus (D-NV), aims to address longstanding barriers that prevent veterans from discussing or accessing medical marijuana under VA care. This move comes as support grows nationwide for expanding healthcare options for veterans, especially regarding pain management and mental health

The amendment is part of a broader wave of legislative and regulatory activity around cannabis and psychedelics at both state and federal levels. In a related development, a coalition of 32 members of Congress has urged the Food and Drug Administration to accelerate the approval of psychedelic therapies, emphasizing the need for "transparency, urgency and scientific rigor." These efforts reflect increasing momentum in Congress to modernize drug policy and respond to the evolving needs of veterans and other patient populations

Opponents of cannabis reform remain active as well. Indiana Senator Jim Banks (R-IN) recently sent a letter to Governor Mike Braun, urging him to "maintain the state's prohibitions on marijuana use" in response to growing speculation that federal cannabis rescheduling could make state-level legalization more likely. Meanwhile, several states are considering or enacting new cannabis regulations, such as California's approval of drive-thru marijuana dispensaries and Connecticut's move to reinstate THC potency caps for cannabis flower

Scientific research continues to influence the policy debate. A new study published by the American Medical Association found that "psilocybin shows promise as a novel treatment for cocaine use disorder," adding to a growing body of evidence supporting the therapeutic potential of both cannabis and psychedelics. Additionally, research highlighted the antimicrobial properties of Cannabis sativa L. leaf co-products, suggesting further untapped applications in health and wellness

The business landscape is also evolving, with companies like Trulieve Cannabis Corp. reporting quarterly revenues of $286.8 million and TerrAscend Corp. posting net revenue of $65.5 million. Labor and regulatory issues are in the spotlight, as seen in the National Labor Relations Board's decision to uphold worker protections for pre-roll makers at BeLeaf Medical. As the cannabis and psychedelics sectors experience rapid change, the intersection of patient access, scientific discovery, and economic opportunity is drawing increased attention from lawmakers, regulators, and industry leaders alike

From the OG Lab newsroom perspective, the proposed amendment to allow VA doctors to recommend medical cannabis represents a pivotal shift in federal policy that could significantly improve healthcare options for veterans. With bipartisan support and mounting scientific evidence for alternative therapies, this is a development worth watching as it could set new standards for patient care and regulatory frameworks nationwide